Gestalt Diagnostics Raises $7.5M in Series A

Gestalt Diagnostics Raises $7.5M in Series A

Gestalt Diagnostics, a Spokane, WA-based AI-powered digital pathology solutions provider, has raised $7.5 million in Series A funding.

The round was led by Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds, and angel investors from the Pacific Northwest.

Cowles Ventures is the venture capital arm of Cowles Company, a family-owned firm based in Spokane, Washington. It focuses on early-stage investments in healthcare, media, environmental tech, and B2B SaaS sectors.

The company will use the funding to support broader market adoption, AI enhancements, FDA clearance efforts, and the scaling of its digital pathology solutions.

Gestalt Diagnostics is a company dedicated to revolutionizing pathology with innovative digital solutions. Its flagship product, PathFlow®, is a cloud-based digital pathology platform designed to digitize and streamline pathology workflows. PathFlow® offers pathologists and labs a vendor-neutral, AI-powered environment for image management, diagnosis, collaboration, and case review. Founded in 2017, Gestalt serves healthcare, academic medical centers, and research organizations.

Funding Details

Company: Gestalt Diagnostics

Raised: $7.5M

Round: Series A

Funding Date: April 2025

Lead Investor: Cowles Ventures

Additional Investors: TVF Funds, Inland Imaging Investments, KickStart Funds, Pacific Northwest angel investors

Company Website: https://www.gestaltdiagnostics.com/

Software Category: AI Digital Pathology/ Healthcare